Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1991 Jun;59(6):2023–2028. doi: 10.1128/iai.59.6.2023-2028.1991

Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.

J L Michel 1, L C Madoff 1, D E Kling 1, D L Kasper 1, F M Ausubel 1
PMCID: PMC257960  PMID: 1674738

Abstract

Streptococcus agalactiae (group B streptococci [GBS]) is the leading cause of neonatal sepsis and meningitis in the United States. The surface-associated C proteins of GBS play a role in immunity, but their number, size, structure, function, and virulence properties have not been well characterized. A recombinant library of DNA fragments from GBS strain A909 (type Ia/C) was prepared in the plasmid pUX12, a specially constructed Escherichia coli expression vector. The library was screened with a rabbit antiserum shown to be protective for passive immunity to GBS infection in a mouse lethality model. Clones were divided into two distinct groups on the basis of DNA-DNA cross-hybridization, restriction enzyme analysis, and the expression of antigenic proteins in E. coli. A characteristic clone from each group was chosen for further study. Clone pJMS23 expresses gene products that biochemically and immunologically correspond to the trypsin-resistant, C-protein alpha antigen. Clone pJMS1 expresses a gene product that binds to immunoglobulin A and is similar to the trypsin-sensitive, C-protein beta antigen. Antisera raised in rabbits against E. coli containing each of the plasmid clones were able to elicit protective immunity in mice challenged by GBS strains carrying the C proteins but not by non-C-protein-bearing strains. Southern blot analysis shows no DNA homology between the clones, and there is no immunological cross-reactivity between the antigens they express. Therefore, pJMS23 and pJMS1 encode two different C proteins that define unique protective epitopes.

Full text

PDF
2023

Images in this article

2025Image
on p.2025
2025Image
on p.2025

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aruffo A., Seed B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8573–8577. doi: 10.1073/pnas.84.23.8573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baker C. J. Immunization to prevent group B streptococcal disease: victories and vexations. J Infect Dis. 1990 May;161(5):917–921. doi: 10.1093/infdis/161.5.917. [DOI] [PubMed] [Google Scholar]
  3. Baker C. J., Rench M. A., Edwards M. S., Carpenter R. J., Hays B. M., Kasper D. L. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med. 1988 Nov 3;319(18):1180–1185. doi: 10.1056/NEJM198811033191802. [DOI] [PubMed] [Google Scholar]
  4. Bevanger L. Ibc proteins as serotype markers of group B streptococci. Acta Pathol Microbiol Immunol Scand B. 1983 Aug;91(4):231–234. doi: 10.1111/j.1699-0463.1983.tb00038.x. [DOI] [PubMed] [Google Scholar]
  5. Bevanger L., Iversen J. The Ibc protein fraction of group B streptococci: characterization of protein antigens extracted by HCL. Acta Pathol Microbiol Scand B. 1981 Aug;89(4):205–209. doi: 10.1111/j.1699-0463.1981.tb00177_89b.x. [DOI] [PubMed] [Google Scholar]
  6. Bevanger L., Maeland J. A. Complete and incomplete Ibc protein fraction in group B streptococci. Acta Pathol Microbiol Scand B. 1979 Feb;87B(1):51–54. doi: 10.1111/j.1699-0463.1979.tb02402.x. [DOI] [PubMed] [Google Scholar]
  7. Bevanger L. The Ibc proteins of group B streptococci: isolation of the alpha and beta antigens by immunosorbent chromatography and test for human serum antibodies against the two antigens. Acta Pathol Microbiol Immunol Scand B. 1985 Apr;93(2):113–119. doi: 10.1111/j.1699-0463.1985.tb02861.x. [DOI] [PubMed] [Google Scholar]
  8. Brady L. J., Boyle M. D. Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen. Infect Immun. 1989 May;57(5):1573–1581. doi: 10.1128/iai.57.5.1573-1581.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brady L. J., Daphtary U. D., Ayoub E. M., Boyle M. D. Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay. J Infect Dis. 1988 Nov;158(5):965–972. doi: 10.1093/infdis/158.5.965. [DOI] [PubMed] [Google Scholar]
  10. Briles D. E., Yother J., McDaniel L. S. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S372–S374. doi: 10.1093/cid/10.supplement_2.s372. [DOI] [PubMed] [Google Scholar]
  11. Cleat P. H., Timmis K. N. Cloning and expression in Escherichia coli of the Ibc protein genes of group B streptococci: binding of human immunoglobulin A to the beta antigen. Infect Immun. 1987 May;55(5):1151–1155. doi: 10.1128/iai.55.5.1151-1155.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Coleman S. E., Brady L. J., Boyle M. D. Colloidal gold immunolabeling of immunoglobulin-binding sites and beta antigen in group B streptococci. Infect Immun. 1990 Feb;58(2):332–340. doi: 10.1128/iai.58.2.332-340.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ferrieri P. Neonatal susceptibility and immunity to major bacterial pathogens. Rev Infect Dis. 1990 May-Jun;12 (Suppl 4):S394–S400. doi: 10.1093/clinids/12.supplement_4.s394. [DOI] [PubMed] [Google Scholar]
  14. Ferrieri P. Surface-localized protein antigens of group B streptococci. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S363–S366. doi: 10.1093/cid/10.supplement_2.s363. [DOI] [PubMed] [Google Scholar]
  15. Fischetti V. A., Jones K. F., Hollingshead S. K., Scott J. R. Structure, function, and genetics of streptococcal M protein. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S356–S359. doi: 10.1093/cid/10.supplement_2.s356. [DOI] [PubMed] [Google Scholar]
  16. Heath D. G., Cleary P. P. Fc-receptor and M-protein genes of group A streptococci are products of gene duplication. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4741–4745. doi: 10.1073/pnas.86.12.4741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Helfman D. M., Feramisco J. R., Fiddes J. C., Thomas G. P., Hughes S. H. Identification of clones that encode chicken tropomyosin by direct immunological screening of a cDNA expression library. Proc Natl Acad Sci U S A. 1983 Jan;80(1):31–35. doi: 10.1073/pnas.80.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hollingshead S. K., Fischetti V. A., Scott J. R. Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats. Mol Gen Genet. 1987 May;207(2-3):196–203. doi: 10.1007/BF00331578. [DOI] [PubMed] [Google Scholar]
  19. Hull R. A., Gill R. E., Hsu P., Minshew B. H., Falkow S. Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect Immun. 1981 Sep;33(3):933–938. doi: 10.1128/iai.33.3.933-938.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Johnson D. R., Ferrieri P. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol. 1984 Apr;19(4):506–510. doi: 10.1128/jcm.19.4.506-510.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jones K. F., Hollingshead S. K., Scott J. R., Fischetti V. A. Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8271–8275. doi: 10.1073/pnas.85.21.8271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lancefield R. C., McCarty M., Everly W. N. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med. 1975 Jul 1;142(1):165–179. doi: 10.1084/jem.142.1.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lopilato J., Bortner S., Beckwith J. Mutations in a new chromosomal gene of Escherichia coli K-12, pcnB, reduce plasmid copy number of pBR322 and its derivatives. Mol Gen Genet. 1986 Nov;205(2):285–290. doi: 10.1007/BF00430440. [DOI] [PubMed] [Google Scholar]
  24. Madoff L. C., Michel J. L., Kasper D. L. A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci. Infect Immun. 1991 Jan;59(1):204–210. doi: 10.1128/iai.59.1.204-210.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nag D. K., Huang H. V., Berg D. E. Bidirectional chain-termination nucleotide sequencing: transposon Tn5seq1 as a mobile source of primer sites. Gene. 1988 Apr 15;64(1):135–145. doi: 10.1016/0378-1119(88)90487-8. [DOI] [PubMed] [Google Scholar]
  26. Norrander J., Kempe T., Messing J. Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis. Gene. 1983 Dec;26(1):101–106. doi: 10.1016/0378-1119(83)90040-9. [DOI] [PubMed] [Google Scholar]
  27. Payne N. R., Ferrieri P. The relation of the Ibc protein antigen to the opsonization differences between strains of type II group B streptococci. J Infect Dis. 1985 Apr;151(4):672–681. doi: 10.1093/infdis/151.4.672. [DOI] [PubMed] [Google Scholar]
  28. Payne N. R., Kim Y. K., Ferrieri P. Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci. Infect Immun. 1987 May;55(5):1243–1251. doi: 10.1128/iai.55.5.1243-1251.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rubens C. E., Wessels M. R., Heggen L. M., Kasper D. L. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7208–7212. doi: 10.1073/pnas.84.20.7208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Russell-Jones G. J., Gotschlich E. C., Blake M. S. A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen. J Exp Med. 1984 Nov 1;160(5):1467–1475. doi: 10.1084/jem.160.5.1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Russell-Jones G. J., Gotschlich E. C. Identification of protein antigens of group B streptococci, with special reference to the Ibc antigens. J Exp Med. 1984 Nov 1;160(5):1476–1484. doi: 10.1084/jem.160.5.1476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stevens D. L., Tanner M. H., Winship J., Swarts R., Ries K. M., Schlievert P. M., Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989 Jul 6;321(1):1–7. doi: 10.1056/NEJM198907063210101. [DOI] [PubMed] [Google Scholar]
  33. Valtonen M. V., Kasper D. L., Levy N. J. Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody. Microb Pathog. 1986 Apr;1(2):191–204. doi: 10.1016/0882-4010(86)90021-5. [DOI] [PubMed] [Google Scholar]
  34. Wilkinson H. W., Eagon R. G. Type-specific antigens of group B type Ic streptococci. Infect Immun. 1971 Nov;4(5):596–604. doi: 10.1128/iai.4.5.596-604.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wilkinson H. W., Moody M. D. Serological relationships of type I antigens of group B streptococci. J Bacteriol. 1969 Feb;97(2):629–634. doi: 10.1128/jb.97.2.629-634.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES